These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8583391)

  • 1. Effect of KBT-3022, a new diphenylthiazole derivative, on platelet functions.
    Yokota K; Yamamoto N; Morimoto Y; Yamashita A; Oda M
    J Pharm Pharmacol; 1995 Sep; 47(9):768-74. PubMed ID: 8583391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022.
    Shimazawa M; Takiguchi Y; Umemura K; Kondo K; Nakashima M
    Eur J Pharmacol; 1997 Jun; 328(2-3):183-9. PubMed ID: 9218700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of the new anti-platelet agent KBT-3022 and its metabolite on rabbit neutrophil function in vitro.
    Yokota K; Yamamoto N; Obata Y; Oda M
    Jpn J Pharmacol; 1996 Apr; 70(4):291-302. PubMed ID: 8847836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of action of KBT-3022, a new antiplatelet agent.
    Matsuo K; Yokota K; Yamashita A; Oda M
    Gen Pharmacol; 1997 Feb; 28(2):229-35. PubMed ID: 9013200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of KBT-3022, a new cyclooxygenase inhibitor, on experimental brain edema in vitro and in vivo.
    Yamamoto N; Yokota K; Yamashita A; Oda M
    Eur J Pharmacol; 1996 Feb; 297(3):225-31. PubMed ID: 8666054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vitro platelet aggregation and its inhibition by three antithrombotic drugs between human and guinea pig.
    Huang ZS; Lee TK
    Proc Natl Sci Counc Repub China B; 1991 Feb; 15(1):8-14. PubMed ID: 1946813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-thrombotic activity of KBT-3022 in experimental models of thrombosis.
    Yokota K; Yamashita A; Oda M
    Jpn J Pharmacol; 1995 Jun; 68(2):201-6. PubMed ID: 7563977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
    Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
    Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
    Lin CH; Kuo YH; Lin YL; Teng CM
    J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of KBT-3022, a new anti-platelet agent, on hemorheological properties in guinea pigs.
    Yamamoto N; Yokota K; Yamashita A; Oda M
    Thromb Haemost; 1995 Jan; 73(1):118-21. PubMed ID: 7740482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
    Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
    Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of rabbit platelet function on simultaneous administration of ticlopidine hydrochloride and OKY-046.
    Kosugi T; Nakamura M; Saitoh S; Kinjoh K
    Int J Tissue React; 1991; 13(3):123-9. PubMed ID: 1960013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anethole dithiolthione on human platelet aggregation.
    Selley ML; McGuiness JA; Bartlett MR; Ardlie NG
    Arzneimittelforschung; 1992 Mar; 42(3):318-21. PubMed ID: 1497692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
    Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
    Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-platelet actions of FR122047, a novel cyclooxygenase inhibitor.
    Dohi M; Sakata Y; Seki J; Namikawa Y; Fujisaki J; Tanaka A; Takasugi H; Motoyama Y; Yoshida K
    Eur J Pharmacol; 1993 Oct; 243(2):179-84. PubMed ID: 8276067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.